Back to article: Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19


FIGURE 3: I-TAC levels in patient plasma.(A) I-TAC levels were measured using ELISA kits. Early plasma (25 µl) were diluted to 100 µl and added to anti-I-TAC mixture coated wells in duplicate. Data were groups by disease stage and expressed as mean ± SD. (B) Statistical analysis of I-TAC levels with disease stages. (C) Association of early plasma I-TAC levels with hospitalization time of survived patients (n=34). (D) I-TAC levels at time closest to discharge. ID1010: 7 days before discharge; ID1015: 8 days before discharge; ID1006: 6 days before discharge; ID1001: 2 days before discharge; ID1028: 7 days before discharge. Admission: within 3 days of hospitalization. (E) Changes of I-TAC level after admission. Red number day: sample collection time. Green number day and green triangle: discharged live. Blue number day and blue triangle: discharged deceased. (F) Association of early plasma I-TAC with concomitant comorbidities. Comorbidities and patient numbers in each group (n) were indicated. *, p<0.05.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.

Close